drugset / Trial / NCT03120182

Chronic Subdural Hematoma and Aspirin

NCT03120182 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this randomized, blinded, placebo controlled clinical study is to compare the peri- and postoperative bleeding and cardiovascular complication rates of patients undergoing burr-hole trepanation for chronic subdural hematoma with and without discontinuation of low-dose aspirin

Timeline

Start
2018-02-19
Primary completion
2023-12-31
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg Oral

Indications

No indication recorded.